Low-Level Laser Therapy for Closed-Head Traumatic Brain Injury in Mice: Effect of Different Wavelengths

Background and Objectives Traumatic brain injury (TBI) affects millions worldwide and is without effective treatment. One area that is attracting growing interest is the use of transcranial low‐level laser therapy (LLLT) to treat TBI. The fact that near‐infrared light can penetrate into the brain wo...

Full description

Saved in:
Bibliographic Details
Published inLasers in surgery and medicine Vol. 44; no. 3; pp. 218 - 226
Main Authors Wu, Qiuhe, Xuan, Weijun, Ando, Takahiro, Xu, Tao, Huang, Liyi, Huang, Ying-Ying, Dai, Tianghong, Dhital, Saphala, Sharma, Sulbha K., Whalen, Michael J., Hamblin, Michael R.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.03.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background and Objectives Traumatic brain injury (TBI) affects millions worldwide and is without effective treatment. One area that is attracting growing interest is the use of transcranial low‐level laser therapy (LLLT) to treat TBI. The fact that near‐infrared light can penetrate into the brain would allow non‐invasive treatment to be carried out with a low likelihood of treatment‐related adverse events. LLLT may treat TBI by increasing respiration in the mitochondria, causing activation of transcription factors, reducing inflammatory mediators and oxidative stress, and inhibiting apoptosis. Study Design/Materials and Methods We tested LLLT in a mouse model of closed‐head TBI produced by a controlled weight drop onto the skull. Mice received a single treatment with continuous‐wave 665, 730, 810, or 980 nm lasers (36 J/cm2 delivered at 150 mW/cm2) 4‐hour post‐TBI and were followed up by neurological performance testing for 4 weeks. Results Mice with moderate‐to‐severe TBI treated with 665 and 810 nm laser (but not with 730 or 980 nm) had a significant improvement in Neurological Severity Score that increased over the course of the follow‐up compared to sham‐treated controls. Morphometry of brain sections showed a reduction in small deficits in 665 and 810 nm laser treated mouse brains at 28 days. Conclusions The effectiveness of 810 nm agrees with previous publications, and together with the effectiveness of 660 nm and non‐effectiveness of 730 and 980 nm can be explained by the absorption spectrum of cytochrome oxidase, the candidate mitochondrial chromophore in transcranial LLLT. Lasers Surg. Med. 44:218–226, 2012. © 2012 Wiley Periodicals, Inc.
Bibliography:istex:CCCA9694BBA47E16A799F47C8BD499B2F6223AD3
ark:/67375/WNG-8TNZ94VD-C
CDMRP Program in TBI - No. W81XWH-09-1-0514
Air Force Office of Scientific Research - No. FA9950-04-1-0079
Center for Integration of Medicine and Innovative Technology - No. DAMD17-02-2-0006
ArticleID:LSM22003
Conflict of interest: None reported.
NIH - No. R01AI050875
ISSN:0196-8092
1096-9101
DOI:10.1002/lsm.22003